Patient info Open main menu

Roclanda - patient leaflet, side effects, dosage

Contains active substance:

Dostupné balení:

Patient leaflet - Roclanda

B. PACKAGE LEAFLET

Package leaflet: Information for the patient

Roclanda 50 micrograms/ml + 200 micrograms/ml eye drops, solution latanaprost + netarsudil

This medicine is subject to additional monitoring. This will allow quick identification of new safety nformation. You canhelp by reporting any side effects you may get. See the end of section 4 forhow to report side effects.

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • – Keep this leaflet. You may need to read it again.

  • – If you have any further questions, ask your doctor or pharmacist.

  • – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them,

even if their signs of illness are the same as yours.

- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

  • 1. What Roclanda is and what it is used for

  • 2. What you need to know before you use Roclanda

  • 3. How to use Roclanda

  • 4. Possible side effects

  • 5. How to store Roclanda

  • 6. Contents of the pack and other information

1. What Roclanda is and what it is used for

Roclanda contains the active substances latanoprost and netarsudil. Latanoprost belongs to a group of medicines known as prostaglandin analogues. Netarsudil belongs to a group of medicines called Rho kinase inhibitors. They work in different ways to reduce the amount of fluid, and so lower the pressure, inside the eye.

Roclanda is used to lower pressure in the eyes in adults who have an eye condition known as glaucoma or who have raised pressure in their eyes. If the pressure in the eye is too high, it can damage your sight.

2. What you need to know before you use Roclanda

Do not use Roclanda

  • – if you are allergic to latanoprost or netarsudil or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before using Roclanda if you think any of the following applies to you:

  • If you suffer from dry eyes;
  • If you have severe asthma or asthma that is not well controlled;
  • If you have suffered or are currently suffering from a viral infection of the eye caused by the

herpes simplex virus.

Do not use Roclanda more than once a day, as you may experience more side effects.

Children and adolescents

Roclanda should not be used in children and adolescents under 18 years of age as it is not known if it is safe or effective in this age group.

Other medicines and Roclanda

Roclanda may interact with other medicines. Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines, especially any that contain another prostaglandin analogue like latanoprost.

Pregnancy and breast-feeding

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Do not use Roclanda if you are pregnant.

Driving and using machines

You may find that your vision is blurred or abnormal just after using Roclanda. Do not drive or use machines until your vision has cleared.

Roclanda contains benzalkonium chloride

This medicine contains benzalkonium chloride which may be absorbed by soft contact lenses and change the colour of the contact lenses. You should remove contact lenses before using this medicine and not put them back before 15 minutes has passed.

Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.

3. How to use Roclanda

Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Only use Roclanda for your eyes (ocular use).

The recommended dose is one drop in the affected eye once a day in the evening. Use the medicine at around the same time each day. Do not use it more than once a day.

How to use

  • Wash your hands before you start.
  • Do not touch the dropper tip with your fingers when opening or closing the bottle. It could infect the eye drops.
  • Twist off the bottle cap, and lie the cap on a clean surface on its side. Continue to hold the

bottle, ensuring that the tip doesn’t come into contact with anything.

  • Hold the bottle, pointing down, between your thumb and fingers.
  • Tilt your head back.
  • Pull down your lower eyelid with a clean finger to form a ‘pocket’ between the eyelid and your eye. The drop will go in here.
  • Bring the dropper tip close to the eye. Do this in front of a mirror if it helps.
  • Do not touch your eye, eyelid, surrounding areas or other surfaces with the dropper tip. It could infect the eye drops.
  • Gently squeeze the bottle to release one drop of Roclanda into your eye.
  • Only put one drop into your eye each time. If a drop misses your eye, try again.
  • Press a finger against the corner of the eye by the nose. Hold for 1 minute whilst keeping the

eye closed.

  • If you need to use the drops in both eyes, repeat the steps for your other eye while you have the bottle open.
  • Put back the bottle cap to close the bottle.
  • Put the bottle back into the carton to protect the drops from light until you need to use the drops again.

If you are using other eye drops , wait at least five minutes after using them and then use Roclanda. If you are using an eye ointment, it should be used last.

If you use more Roclanda than you should

Rinse your eye with warm water. Do not put in any more drops until it is time for your next regular dose.

If you forget to use Roclanda

Continue with the next dose as planned. Do not use a double dose to make up for a forgotten dose. Do not use more than one drop in the affected eye once a day.

If you stop using Roclanda

Do not stop using Roclanda without first speaking to your doctor. If you stop using Roclanda the pressure in your eye will not be controlled which could lead to loss of sight.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been observed with Roclanda and other medicines containing latanoprost and netarsudil alone:

  • Very common (may affect more than 1 in 10 people)

Effects in the eye:

■ Eye redness; fine deposits on the front of the eye and pain where the drops have been put in; a gradual increase in the amount of brown pigment in the coloured part of the eye (the iris) leading to altered eye colour; a gradual increase in the colour (darkening), length, thickness and number of your eye lashes.

  • Common (may affect up to 1 in 10 people)

Effects in the eye:

  • ■ Infection or inflammation of the eye; dryness of the eye or small breaks in the film of liquid on the surface of the eye; eye discharge; itchy eyelids; clouding of the eye and slight decrease in vision; eye pain; feeling of grittiness or having something in the eye; general eye redness shortly after drops are put in; spots or patches of eye redness; conjunctivitis (eye inflammation or prominent blood vessels) caused by an allergic reaction; watery eyes; increased sensitivity to light; swelling around the eye; eyelid crusting; blurred vision;

General side effects

  • ■ redness or itching of the skin on your face

  • Uncommon (may affect up to 1 in 100 people)

Effects in the eye:

  • ■ Increased fluid pressure inside the eye; inflammation of the coloured part of the eye (the iris); bulging of iris; increased wrinkling of the clear layer over the eye where it meets with the lower eyelid; blindness; blurred, double or halo vision; blocked tear duct; small colored spots on the eye surface; eyelid dryness; eye dryness caused by inflammation of the glands of the eyelids; eye allergy; shiny/glassy eyes; tiredness; numbness or burning in the eye; abnormal turning outward of the lower eyelid; loss of eyelashes; eye disease related to diabetes

Side effects in other parts of the body

  • ■ Blocked nose; nosebleed; nasal discomfort and pain; headache; dizziness; redness or itching of the skin; dry skin; thickening of the skin; muscle pain or spasm; joint pain; jaw pain; picking at your skin; inflammation of the cartilage; chest pain (angina); awareness of heart beat (palpitations); asthma; shortness of breath (dyspnoea)

  • Rare (may affect up to 1 in 1000 people)

Effects in the eye:

  • ■ Swelling or scratching with damage to the surface of the eye; swelling around the eye (periorbital oedema); eyelashes growing in the wrong direction or an extra row of eyelashes; scarring of the surface of the eye; fluid filled area within the coloured part of the eye (iris cyst); skin reactions on the eyelids; darkening of the skin of the eyelids; viral infection of the eye caused by herpes simplex virus (HSV).

Side effects in other parts of the body

  • ■ Worsening of asthma; severe itching of the skin

  • Very rare (may affect up to 1 in 10,000 people)

Effects in the eye:

  • ■ Sunken eye appearance (eye sulcus deepening).

Side effects in other parts of the body

  • ■ Worsening of angina in patients who also have heart disease

Reporting of side effects

If you get any side effects, talk to your doctor, or pharmacist. This includes any possible side effects not listed in this leaflet. Y ou can also report side effects directly via the national reporting system listed in Appendix V. By reporting side affects you can help provide more information on the safety of this medicine.

5. How to store Roclanda

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the bottle and the carton after “EXP”.

The expiry date refers to the last day of that month.

Unopened bottle: Store in a refrigerator (2 °C – 8 °C).

After opening the bottle: Do not store above 25 °C.

Store in the original carton in order to protect from light.

Throw away the bottle 4 weeks after first opening to prevent infections and use a new bottle.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Roclanda contains

  • – The active substances are latanoprost and netarsudil. Each ml of solution contains 50 micrograms latanoprost and 200 micrograms netarsudil (as mesylate).

  • – The other excipients are benzalkonium chloride (see section 2 under ‘Roclanda contains benzalkonium chloride’), mannitol, boric acid, sodium hydroxide (for pH adjustment) and water for injections.

What Roclanda looks like and contents of the pack

Roclanda is a clear, liquid eye drop solution in a plastic bottle. Each bottle contains 2.5 ml of the medicine and each pack contains one bottle with a screw-cap.

Marketing Authorisation Holder

Santen Oy

Niittyhaankatu 20, 33720 Tampere, Finland

Manufacturer

Aerie Pharmaceuticals Ireland, Limited

Athlone Business and Technology Park, Dublin Road,

Garrycastle, Athlone, Co Westmeath, N37 DW40, Ireland.

and

Santen Oy, Kelloportinkatu 1, 33100 Tampere, Finland

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

Belgie/Belgiqu­e/Belgien

Santen Oy

Tél/Tel : +32 (0) 24019172

Lietuva

Santen Oy

Tel: +370 37 366628

Etnrapun

Santen Oy

Ten.: +359 (0) 888 755 393

Luxembourg/Lu­xemburg

Santen Oy

Tel/Tel : +352 (0) 27862006

Česká republika

Santen Oy

Tel: : +420 234 102 170

Magyarorszag

Santen Oy

Tel: +36 (06) 16777305

Danmark

Santen Oy

Tlf: +45 78737843

Malta

Santen Oy

Tel: + 358 (0) 3 284 8111

Deutschland

Santen GmbH

Tel: +49 (0) 3030809610

Nederland

Sant en Oy

Tel: +31 (0) 207139206

Eesti

Santen Oy

Tel: +372 5067559

Norge

SantenPharma AB

Tlf: +47 21939612

EXXáSa

Santen Oy

Österreich

Santen Oy

Tql: + 358 (0) 3 284 8111

Tel: +43 (0) 720116199

España

Santen Pharmaceutical Spain S.L.

Tel: + 34 914 142 485

Polska

Santen Oy

Tel.: +48 (0) 221168608

France

Santen

Tél: +33 (0) 1 70 75 26 84

Portugal

Santen Oy

Tel: + 351 308 805 912

Hrvatska

Santen Oy

Tel: + 358 (0) 3 284 8111

Romania

Santen Oy

Tel: +40 (0) 316300603

Ireland

Santen UK Limited

Tel: + 353 (0) 16950008

Slovenija

Santen Oy

Tel: + 358 (0) 3 284 8111

Ísland

Santen Oy

Sími: + 358 (0) 3 284 8111

Slovenská republika

Santen Oy

Tel: +421 (01) 23 332 5519

Italia

Santen Italy S.r.l.

Tel: +39 0236009983

Suomi/Finland

Santen Oy

Puh/Tel: +358 (0) 974790211

Kúnpog

Santen Oy

Tql: + 358 (0) 3 284 8111

Sverige

Santen Oy

Tel: +46 (0) 850598833

Latvija

Santen Oy

Tel: +371 677 917 80

United Kingdom (Northern Ireland)

Santen UK Limited

Tel: + 44 (0) 845 075 4863

This leaflet was last revised in

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency web site:

.

28